Suppr超能文献

利用 WGS 探索尼日利亚拉各斯地区耐多药结核分枝杆菌复合体的多样性:谱系分布、耐药模式和基因突变。

Exploration of the diversity of multi-drug resistant Mycobacterium tuberculosis complex in Lagos, Nigeria using WGS: Distribution of lineages, drug resistance patterns and genetic mutations.

机构信息

Integrative Pharmacogenomics Institute, Universiti Teknologi MARA Selangor Branch, Puncak Alam Campus, Selangor, Malaysia; Faculty of Pharmacy, Universiti Teknologi MARA Selangor Branch, Puncak Alam Campus, Selangor, Malaysia.

Integrative Pharmacogenomics Institute, Universiti Teknologi MARA Selangor Branch, Puncak Alam Campus, Selangor, Malaysia.

出版信息

Tuberculosis (Edinb). 2023 May;140:102343. doi: 10.1016/j.tube.2023.102343. Epub 2023 Apr 16.

Abstract

Multidrug-resistant (MDR) or extensively drug-resistant (XDR) Tuberculosis (TB) is a major challenge to global TB control. Therefore, accurate tracing of in-country MDR-TB transmission are crucial for the development of optimal TB management strategies. This study aimed to investigate the diversity of MTBC in Nigeria. The lineage and drug-resistance patterns of the clinical MTBC isolates of TB patients in Southwestern region of Nigeria were determined using the WGS approach. The phenotypic DST of the isolates was determined for nine anti-TB drugs. The sequencing achieved average genome coverage of 65.99X. The most represented lineages were L4 (n = 52, 83%), L1 (n = 8, 12%), L2 (n = 2, 3%) and L5 (n = 1, 2%), suggesting a diversified MTB population. In term of detection of M/XDR-TB, while mutations in katG and rpoB genes are the strong predictors for the presence of M/XDR-TB, the current study also found the lack of good genetic markers for drug resistance amongst the MTBC in Nigeria which may pose greater problems on local tuberculosis management efforts. This high-resolution molecular epidemiological data provides valuable insights into the mechanistic for M/XDR TB in Lagos, Nigeria.

摘要

耐多药(MDR)或广泛耐药(XDR)结核病(TB)是全球结核病控制的主要挑战。因此,准确追踪国内 MDR-TB 的传播对于制定最佳结核病管理策略至关重要。本研究旨在调查尼日利亚分枝杆菌复合体(MTBC)的多样性。本研究采用 WGS 方法,确定了尼日利亚西南部地区结核病患者临床 MTBC 分离株的谱系和耐药模式。对分离株进行了 9 种抗结核药物的表型 DST。测序平均实现了 65.99X 的基因组覆盖率。最主要的谱系为 L4(n=52,83%)、L1(n=8,12%)、L2(n=2,3%)和 L5(n=1,2%),表明 MTB 群体多样化。在检测 M/XDR-TB 方面,虽然 katG 和 rpoB 基因突变是存在 M/XDR-TB 的强有力预测因子,但本研究还发现,尼日利亚 MTBC 中缺乏耐药性的良好遗传标志物,这可能给当地结核病管理工作带来更大的问题。这项高分辨率分子流行病学数据为尼日利亚拉各斯 M/XDR-TB 的发病机制提供了有价值的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验